Common use of Filing Financing Statements Clause in Contracts

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232024-2 4 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232024-2 4 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232024-2 4 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232021-2 1 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232021-2 1 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232021-2 1 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 4 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 4 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 4 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 7 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 7 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 7 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 4 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 4 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 4 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 7 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 7 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 7 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 5 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 5 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 5 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 1 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 1 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 1 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 1 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 1 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 1 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232021-2 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232021-2 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232021-2 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232024-2 1 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232024-2 1 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232024-2 1 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232024-2 3 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232024-2 3 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232024-2 3 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 3 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 3 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 3 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232024-2 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232024-2 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232024-2 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 6 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 6 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 6 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232024-2 5 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232024-2 5 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232024-2 5 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 6 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 6 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 6 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 20232022-2 5 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 20232022-2 5 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 20232022-2 5 Secured Parties.”

Filing Financing Statements. The Trust has caused, or will cause within ten (10) days after the Closing Date, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under applicable law to perfect the security interest Granted in the Series 2023-2 3 Collateral to the Indenture Trustee under this Indenture. All financing statements filed or to be filed against the Trust in favor of the Indenture Trustee under this Indenture describing the Series 2023-2 3 Collateral will contain a statement to the following effect: “A purchase, absolute assignment or transfer of or grant of a security interest in any collateral described in this financing statement will violate the rights of the Series 2023-2 3 Secured Parties.”